{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Pulse Biosciences, Inc"},"Symbol":{"label":"Symbol","value":"PLSE"},"Address":{"label":"Address","value":"3957 POINT EDEN WAY, HAYWARD, California, 94545, United States"},"Phone":{"label":"Phone","value":"+1 510 906-4600"},"Industry":{"label":"Industry","value":"Medical/Dental Instruments"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"Pulse Biosciences Inc is a medical therapy company that pursues the commercial introduction of its proprietary CellFX System utilizing its patent-protected Nano-Pulse Stimulation (NPS) platform technology. Through its proprietary CellFX System, the company can deliver a cell-focused effect on dysfunctional cells while preserving surrounding non-cellular tissue, a combination that may potentially lead to both improved efficacy and less collateral tissue damage. Substantial revenue is generated from North America Majorly due to the sale of systems."},"CompanyUrl":{"label":"Company Url","value":"https://www.pulsebiosciences.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Darrin R. Uecker","title":"Co-Chief Executive & Financial Officer"},{"name":"David Danitz","title":"Senior Vice President-Engineering"},{"name":"Dunnington Gansevoort","title":"Chief Medical Officer"},{"name":"Edison Manuel","title":"Vice President-Operations"},{"name":"Richard Nuccitelli","title":"Chief Science Officer"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}